Related Experiment Video
Updated: Dec 8, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease
Xinwei Huang1,2, Dongjin Lv3, Xiao Yang2
1Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, China.
Abstract:
N6-methyladenosine (m6A) RNA methylation, the most prevalent internal chemical modification of mRNA, has been reported to participate in the progression of various tumours via the dynamic regulation of m6A RNA methylation regulators. However, the role of m6A RNA methylation regulators in chronic obstructive pulmonary disease (COPD) has never been reported. This study aimed to determine the expression and potential functions of m6A RNA methylation regulators in COPD. Four gene expression data sets were acquired from Gene Expression Omnibus. Gene ontology function, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses, weighted correlation network analysis and protein-protein interaction network analysis were performed. The correlation analyses of m6A RNA methylation regulators and key COPD genes were also performed. We found that the mRNA expressions of IGF2BP3, FTO, METTL3 and YTHDC2, which have the significant associations with some key genes enriched in the signalling pathway and biological processes that promote the development progression of COPD, are highly correlated with the occurrence of COPD. In conclusion, six central m6A RNA methylation regulators could contribute to the occurrence of COPD. This study provides important evidence for further examination of the role of m6A RNA methylation in COPD.
Insights
N6-methyladenosine (m6A) RNA methylation regulators are linked to chronic obstructive pulmonary disease (COPD). This study identifies key regulators potentially involved in COPD development, offering new research avenues.
Area of Science:
- Epigenetics
- Molecular Biology
- Pulmonology
Background:
- N6-methyladenosine (m6A) RNA methylation is crucial in various cancers.
- m6A regulators' role in chronic obstructive pulmonary disease (COPD) remains unexplored.
Purpose of the Study:
- To investigate the expression and function of m6A RNA methylation regulators in COPD.
- To identify potential correlations between m6A regulators and COPD pathogenesis.
Main Methods:
- Analysis of four Gene Expression Omnibus datasets.
- Gene Ontology and KEGG pathway enrichment analyses.
- Weighted correlation network and protein-protein interaction network analyses.
Main Results:
- Identified significant associations between specific m6A regulators (IGF2BP3, FTO, METTL3, YTHDC2) and key COPD-related genes.
- Found high correlations between these regulators' mRNA expression and COPD occurrence.
- Highlighted involvement in signaling pathways and biological processes promoting COPD development.
Conclusions:
- Six central m6A RNA methylation regulators may contribute to COPD occurrence.
- Provides foundational evidence for further research into m6A methylation's role in COPD.
Related Concept Videos
Master Transcription Regulators
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Stability
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

